Reaction
Atopy reporting signals
As of the last recalculation, Atopy appears in 275 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is CICLESONIDE (PRR 453.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ciclesonide | 63 | 453.8 | 455.9 |
| Goserelin | 51 | 352.7 | 354.1 |
| Bicalutamide | 50 | 303.3 | 304.3 |
| Sodium Bicarbonate | 44 | 170.3 | 170.6 |
| Sodium Bicarbonate Injection, | 44 | 170.3 | 170.6 |
| Fluticasone Propionate And Salmeterol Xinafoate | 66 | 109.1 | 109.2 |
| Salmeterol Xinafoate | 11 | 100.6 | 100.7 |
| Calcium Gluconate | 14 | 92.6 | 92.7 |
| Mepolizumab | 49 | 90.6 | 90.7 |
| Fluticasone Furoate | 12 | 78.4 | 78.4 |
| Itraconazole | 8 | 53.4 | 53.4 |
| Fluticasone Furoate And Vilanterol Trifenatate | 18 | 40.5 | 40.5 |
| Timolol | 5 | 31.9 | 31.9 |
| Guselkumab | 6 | 13.0 | 13.0 |